Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Items 301–400 of 698
Jawitz, O. K., Raman, V., Bryner, B. S., Klapper, J., & Hartwig, M. G. (2021) · Transplant International · doi:10.1111/tri.13784 · Cited by 12
Long-Term Survival Following Primary Graft Dysfunction Development in Lung Transplantation
Gouchoe, D. A., Whitson, B. A., Rosenheck, J. P., Henn, M. C., Mokadam, N. A., Ramsammy, V., Kirkby, S. E., Nunley, D. R., & Ganapathi, A. M. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2023.12.006 · Cited by 12
Gouchoe, D. A., Cui, E. Y., Satija, D., Henn, M. C., Choi, K., Rosenheck, J. P., Nunley, D. R., Mokadam, N. A., Ganapathi, A. M., & Whitson, B. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154440 · Cited by 12
Kolaitis, N. A., Barnes, H., Levine, D. J., Castillo, H., Arcasoy, S. M., Bacchetta, M. D., Benvenuto, L. J., Rosenzweig, E. B., Cevasco, M., Demarest, C. T., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70088 · Cited by 13
Self-citationExtracorporeal Membrane Oxygenation as a Bridge to Lung Transplant
Stokes, J. W., Gannon, W. D., & Bacchetta, M. D. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1728795 · Cited by 13
Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant
McQuiston, A. S., Emtiazjoo, A. M., Angel, P. M., Machuca, T., Christie, J. D., & Atkinson, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711102 · Cited by 13
“Pre-Existing Autoantibodies and Primary Graft Dysfunction Primary graft dysfunction (PGD) is a progressive acute lung injury syndrome that manifests within the first 72 hours after lung transplantation and affects 25-30% of LTx patients (35).”
BackgroundSelf-citationNew-onset Obesity After Lung Transplantation: Incidence, Risk Factors, and Clinical Outcomes
Jomphe, V., Bélanger, N., Beauchamp‐Parent, C., Poirier, C. D., Nasir, B., Ferraro, P., Lands, L. C., & Mailhot, G. (2022) · Transplantation · doi:10.1097/tp.0000000000004222 · Cited by 13
Lymphocytic Airway Inflammation in Lung Allografts
Santos, J., Calabrese, D. R., & Greenland, J. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908693 · Cited by 12
“PGD risk is also driven by non-ischemic mediators of graft injury, including recipient BMI, donor tobacco use, and operative transfusions as stated above (47).”
BackgroundOtto, M., McGiffin, D. C., Whitford, H. M., Kure, C., Snell, G. I., Diehl, A., Orosz, J., & Burrell, A. J. C. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154120 · Cited by 12
Elde, S., Huddleston, S. J., Jackson, S., Kelly, R. F., Shumway, S. J., & Loor, G. (2017) · Surgical Infections · doi:10.1089/sur.2017.144 · Cited by 12
“The finding that increased time on CPB led to increased PGD in our cohort is supported by others who have found CPB to be an important risk factor for PGD [11,12].”
Frick, A. E., Verleden, S. E., Ordies, S., Sacreas, A., Vos, R., Verleden, G. M., Vanaudenaerde, B. M., Claes, S., Schols, D., Raemdonck, D. E. V., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa043 · Cited by 13
Kolaitis, N. A., Gao, Y., Soong, A., Greenland, J. R., Hays, S. R., Golden, J. A., Leard, L. E., Shah, R., Kleinhenz, M. E., Katz, P., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16257 · Cited by 13
Self-citationCourtwright, A., Kamoun, M., Diamond, J. M., Kearns, J. D., Ahya, V. N., Christie, J. D., Clausen, E. S., Hadjiliadis, D., Patel, N., Salgado, J. C., et al. (2021) · Clinical Transplantation · doi:10.1111/ctr.14447 · Cited by 12
Self-citationNiroomand, A., Qvarnström, S., Stenlo, M., Malmsjö, M., Ingemansson, R., Hyllén, S., & Lindstedt, S. (2022) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14025 · Cited by 12
Sanchez, P. G., Chan, E. G., Davis, R. D., Hartwig, M. G., Machuca, T., Whitson, B. A., Daneshmand, M. A., Ovidio, F. D., Ryan, J. P., DCunha, J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.01.092 · Cited by 12
Self-citationSong, Y. R., Paik, H. C., Kim, N., Jung, H., Lee, J., & Yoo, Y. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226862 · Cited by 12
Self-citationLee, S. H., Lee, J. G., Lee, C. Y., Kim, N., Chang, M.-Y., You, Y.-C., Kim, H. J., Paik, H. C., & Oh, Y. J. (2016) · Medicine · doi:10.1097/md.0000000000003975 · Cited by 12
“Although previous studies have demonstrated that grade 1 is not associated with increased mortality,([14,32]) the reduced severity described in this study is expected, as iloprost is known to improve ventilation/perfusion matching.”
BackgroundResultInfluentialSelf-citationPerioperative Management of the Lung Graft Following Lung Transplantation
Geube, M., Anandamurthy, B., & Yared, J. (2018) · Critical Care Clinics · doi:10.1016/j.ccc.2018.08.007 · Cited by 12
Procedural mechanical support for lung transplantation
Schwarz, S., Höetzenecker, K., & Klepetko, W. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000873 · Cited by 12
“Both, use of high fractions of inspired oxygen during reperfusion [17] as well as high ventilation pressures are known risk factors for ventilatorinduced lung injury of the allograft and consequent development of PGD.”
BackgroundLoor, G., Parulekar, A. D., & Smith, M. A. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.02.139 · Cited by 12
Lung transplantation: Current insights and outcomes
Napoli, C., Benincasa, G., Fiorelli, A., Strozziero, M. G., Costa, D., Russo, F., Grimaldi, V., & Höetzenecker, K. (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102073 · Cited by 12
Amarelli, C., Bello, I., Aigner, C., Berman, M., Boffini, M., Clark, S. C., Dalvindt, M., Wolf, J. D., Ensminger, S. M., de Antonio, D. G., et al. (2024) · Transplant International · doi:10.3389/ti.2024.13112 · Cited by 11
Advancing lung transplantation through machine learning and artificial intelligence
Ronen, L., Keshavjee, S. H., & Sage, A. T. (2025) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001168 · Cited by 12
Liu, X., Chen, W., Du, W., Li, P., & Wang, X. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1583490 · Cited by 11
“PGD, a severe form of acute lung injury that occurs within 72 h following LTx, remains a leading cause of early mortality (66 – 68).”
Natalini, J. G., Diamond, J. M., Porteous, M. K., Lederer, D. J., Wille, K. M., Weinacker, A. B., Orens, J. B., Shah, P. D., Lama, V. N., McDyer, J. F., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.01.1391 · Cited by 12
Self-citationSurgical Complications of Lung Transplantation
Loor, G., Mattar, A., Schaheen, L. W., & Bremner, R. M. (2022) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2022.01.003 · Cited by 15
Critical Care Management Following Lung Transplantation
Jeon, K. (2022) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/jcs.22.067 · Cited by 13
“MV weaning is usually intentionally performed slowly in patients with a high risk of severe graft dysfunction or inadequate gas exchange [32].”
BackgroundWong, W., Johnson, B. N., Cheng, P. C., Josephson, M. B., Maeda, K., Berg, R. A., Kawut, S. M., Harhay, M. O., Goldfarb, S., Yehya, N., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.12.014 · Cited by 11
Self-citationRello, J., Bello, I., Vicente, R., Anchuelo, A. H., Ballesteros, M. Á., Iranzo, R., Rellán, L., Riera, J., & Robles, J. C. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2016.12.017 · Cited by 11
Schiavon, M., Faggi, G., Gregorio, G. D., Calabrese, F. A., Lunardi, F., Marulli, G., Feltracco, P., Loy, M., Damin, M., Cozzi, E., et al. (2017) · Clinical Transplantation · doi:10.1111/ctr.13129 · Cited by 11
Alpha-1 Antitrypsin Attenuates Acute Lung Allograft Injury in a Rat Lung Transplant Model
Emtiazjoo, A. M., Hu, H., Lu, L., & Brantly, M. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000898 · Cited by 11
Bertani, A., Miceli, V., Monte, L. D., Occhipinti, G., Pagano, V., Liotta, R., Badami, E., Tuzzolino, F., & Arcadipane, A. F. (2021) · BioMed Research International · doi:10.1155/2021/6625955 · Cited by 11
“PGD grade 3 is also associated with higher mortality and with the development of bronchiolitis obliterans syndrome (BOS) [1].”
BackgroundCalabrese, F., Pezzuto, F., Fortarezza, F., Lunardi, F., Faccioli, E., Lorenzoni, G., Boscolo, A., Sella, N., Gregori, D., Schiavon, M., et al. (2022) · Cells · doi:10.3390/cells11223681 · Cited by 12
Chan-Dominy, A., Rahiman, S. N., Anders, M. M., & Butt, W. W. (2015) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000410 · Cited by 11
Median Sternotomy for Lung Transplantation
Dark, J. H. (2015) · Operative Techniques in Thoracic and Cardiovascular Surgery · doi:10.1053/j.optechstcvs.2015.07.001 · Cited by 11
Bioengineering of Pulmonary Epithelium With Preservation of the Vascular Niche
Dorrello, N. V., & Vunjak‐Novakovic, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00269 · Cited by 11
CD94 + natural killer cells potentiate pulmonary ischaemia–reperfusion injury
Tsao, T., Qiu, L., Bharti, R., Shemesh, A., Hernandez, A. M., Cleary, S. J., Greenland, N., Santos, J., Shi, R., Bai, L., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.02171-2023 · Cited by 11
Mesenchymal Stromal Cell Therapy in Lung Transplantation
Nykänen, A. I., Liu, M., & Keshavjee, S. H. (2023) · Bioengineering · doi:10.3390/bioengineering10060728 · Cited by 10
Dysregulated alveolar epithelial cell progenitor function and identity in Hermansky-Pudlak syndrome
Wang, J. Y., Michki, S. N., Sitaraman, S., Banaschewski, B. J. H., Jamal, R., Gokey, J. J., Lin, S. M., Katzen, J. B., Basil, M. C., Cantu, E., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.183483 · Cited by 10
“In contrast, β-galactosidase activity was not detected in AT2 cells from WT or HPS mice at 8 weeks of age or WT, HPS1, or HPS2 mice at 48 weeks of age ( p = .005) ( Figure 5E, F ).”
Self-citationCritical Care Management of the Lung Transplant Recipient
Natalini, J. G., & Clausen, E. S. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.10.010 · Cited by 10
Primary graft dysfunction grade correlates with acute kidney injury stage after lung transplantation
Toyoda, T., Thomae, B. L., Kandula, V., Manerikar, A. J., Yagi, Y., Cerier, E. J., Tomic, R., Budinger, G. R. S., Bharat, A., & Kurihara, C. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-256 · Cited by 11
Valenza, F., Coppola, S., Froio, S., Ruggeri, G. M., Fumagalli, J., Villa, A. M., Rosso, L., Mendogni, P., Conte, G., Lonati, C., et al. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-12 · Cited by 10
Hoechter, D. J., & von Dossow, V. (2015) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000268 · Cited by 10
Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor
Takahashi, T., Terada, Y., Pasque, M. K., Itoh, A., Nava, R. G., Puri, V., Kreisel, D., Patterson, A., & Hachem, R. R. (2019) · Clinical Transplantation · doi:10.1111/ctr.13768 · Cited by 10
Huddleston, S. J., Jackson, S., Kane, K., Lemke, N. T., Shaffer, A. W., Soule, M., Hertz, M. I., Shumway, S. J., Qi, S., Perry, T. E., et al. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.05.038 · Cited by 10
Subramani, M. V., Nunley, D. R., & Roman, J. (2021) · Clinical Transplantation · doi:10.1111/ctr.14480 · Cited by 11
2018 ATS BEAR Cage Winning Proposal: Cell-Free DNA to Improve Lung Transplant Outcomes
Agbor-Enoh, S. T. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0458ed · Cited by 10
Gao, X., Tang, M., Li, J., Ma, J., Liu, Z., & Liu, W. (2025) · Respiratory Research · doi:10.1186/s12931-025-03151-7 · Cited by 10
“Despite advancements in donor lung harvest and preservation techniques, 10–25% of lung transplant recipients still experience primary graft dysfunction (PGD) post-surgery [2], leading to mortality within the first 30 days after the operation [3].”
Terada, Y., Li, W., Shepherd, H. M., Takahashi, T., Yokoyama, Y., Bery, A. I., Mineura, K., Bai, Y. Z., Ritter, J. H., Hachem, R. R., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.08.010 · Cited by 9
Cerier, E. J., Kurihara, C., Kaiho, T., Toyoda, T., Manerikar, A. J., Kandula, V., Thomae, B. L., Yagi, Y., Yeldandi, A. V., Kim, S., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.11.006 · Cited by 9
Lung Donation and Transplant Recipient Outcomes at Independent vs Hospital-Based Donor Care Units
Vail, E. A., Wang, X., Schaubel, D. E., Reese, P. P., Cantu, E., Martin, N. D., Abt, P. L., Olthoff, K. M., Kerlin, M. P., Christie, J. D., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17107 · Cited by 9
Self-citationKawana, S., Okazaki, M., Sakaue, T., Hashimoto, K., Nakata, K., Choshi, H., Tanaka, S., Miyoshi, K., Ohtani, S., Ohara, T., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.09.028 · Cited by 9
Disfunción primaria del injerto tras el trasplante pulmonar
López, V. J. S., Miñambres, E., Arista, J. C. R., & Ballesteros, M. Á. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2012.03.017 · Cited by 9
Established and potential predictors of blood loss during lung transplant surgery
Oechslin, P., Zalunardo, M. P., İnci, İ., Schläpfer, M., & Grande, B. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.05.165 · Cited by 9
“Common complications after lung transplantation are early graft dysfunction (primary graft dysfunction (PGD), renal failure (3), infections (4) and blood loss (5), the latter being influenced by various factors in thoracic surgery (6).”
BackgroundNeed for tracheostomy after lung transplant predicts decreased mid‐ and long‐term survival
Huddleston, S. J., Brown, R. Z., Rudser, K. D., Goswami, U., Tomic, R., Lemke, N. T., Shaffer, A. W., Soule, M., Hertz, M. I., Shumway, S. J., et al. (2019) · Clinical Transplantation · doi:10.1111/ctr.13766 · Cited by 9
Kaza, V., Zhu, C., Feng, L., Torres, F., Bollineni, S., Mohanka, M. R., Banga, A., JOERNS, J. O., Mohanakumar, T., Terada, L. S., et al. (2020) · Transplant Immunology · doi:10.1016/j.trim.2020.101271 · Cited by 9
Himebauch, A. S., Wong, W., Wang, Y., McGowan, F. X. J., Berg, R. A., Mascio, C. E., Kilbaugh, T. J., Lin, K. Y., Goldfarb, S., Kawut, S. M., et al. (2020) · Pediatric Transplantation · doi:10.1111/petr.13858 · Cited by 9
Self-citationFrick, A. E., Orlitová, M., Vanstapel, A., Ordies, S., Claes, S., Schols, D., Heigl, T., Kaes, J., Sáez, B., Vos, R., et al. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00371-1 · Cited by 9
Wick, K. D., & Matthay, M. A. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2021.05.002 · Cited by 9
“Donor smoking history increased the odds of grade 3 primary graft dysfunction in a multicenter prospectively enrolled cohort of lung transplant recipients.(53) A prospective study of the association between tobacco exposure and the development of ALI(54) after blunt trauma used plasma levels of cotinine to differentia…”
BackgroundFrailty and genetic risk predict fracture after lung transplantation
Macrae, T. A., Lazo, J. G., Viduya, J., Florez, R., Dewey, K., Gao, Y., Singer, J. P., Hays, S. R., Golden, J. A., Kukreja, J., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2022.11.017 · Cited by 9
Lung Transplantation: A Viable Option for Connective Tissue Disease?
Zhang, N., Liu, S., Zhang, Z., Liu, Y., Mi, L., & Xu, K. (2023) · Arthritis Care & Research · doi:10.1002/acr.25133 · Cited by 10
Lésions d’ischémie-reperfusion en transplantation pulmonaire
Gennai, S., Pison, C. M., & Briot, R. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.018 · Cited by 9
Forker, C. M., Miano, T. A., Reilly, J. P., Oyster, M. L., Porteous, M. K., Cantu, E., Ware, L. B., Diamond, J. M., Christie, J. D., & Shashaty, M. G. S. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15402 · Cited by 9
Self-citationAtchade, E., Elmaleh, Y. D., Zappella, N., Jean‐Baptiste, S., Tran-Dinh, A., Tanaka, S., Snauwaert, A., Lortat‐Jacob, B., Goncalves, O., Godet, C., et al. (2022) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2022.101118 · Cited by 9
Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps
Mittendorfer, M., Pierre, L., Huzevka, T., Schofield, J., Abrams, S. T., Wang, G., Toh, C., Bèchet, N. B., Caprnja, I., Kjellberg, G., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.07.007 · Cited by 10
Post Lung Transplant Primary Graft Dysfunction
Geraci, T. C., Chan, J. C. Y., Niroomand, A., & Chang, S. H. (2025) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2025.04.001 · Cited by 9
Primary graft dysfunction after lung transplantation
López, V. J. S., Miñambres, E., Arista, J. C. R., & Ballesteros, M. Á. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.09.006 · Cited by 8
Ex-vivo lung perfusion therapies: do they add value to organ donation?
Lyengar, A., Schiazza, A. R., & Cantu, E. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000961 · Cited by 8
“7%) and comparable to previous PGD studies [5,6].”
ResultSelf-citationLung Progenitor and Stem Cell Transplantation as a Potential Regenerative Therapy for Lung Diseases
Villa, V. S., & Ren, X. (2024) · Transplantation · doi:10.1097/tp.0000000000004959 · Cited by 9
Effect of donor smoking and substance use on post–lung transplant outcomes
Rappaport, J. M. P., Siddiqui, H. U., Thuita, L. W., Budev, M. M., McCurry, K. R., Blackstone, E. H., Ahmad, U., Mehta, A. C., Akindipe, O., Lane, C. R., et al. (2023) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2023.01.028 · Cited by 8
Mulligan, M. S., Weill, D., Davis, R. D., Christie, J. D., Farjah, F., Singer, J. P., Hartwig, M. G., Sánchez, P. G., Kreisel, D., Ware, L. B., et al. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.08.010 · Cited by 8
Self-citationIncidence and Predictive Factors of Acute Kidney Injury After Off-pump Lung Transplantation
Chaudhry, R., Wanderer, J. P., Mubashir, T., Kork, F., Morse, J. L., Waseem, R., Zaki, J. F. W., Shaw, A., Eltzschig, H. K., & Liang, Y. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.09.021 · Cited by 8
Primed for Injury: Cigarette Smokers and Acute Respiratory Distress Syndrome
Reilly, J. P., & Christie, J. D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001121 · Cited by 9
Self-citationGouchoe, D. A., Vijayakumar, A., Aly, A. H., Cui, E. Y., Essandoh, M. K., Gumina, R. J., Black, S. M., & Whitson, B. A. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-725 · Cited by 7
Xia, W. G., Liu, W. L., Zhao, H., Song, C., Liu, J., Chen, R., Chen, J., Wang, X., Xu, H., & Mao, W. (2025) · Transplantation · doi:10.1097/tp.0000000000005326 · Cited by 7
Fessler, J., Gouy‐Pailler, C., Ma, W., Devaquet, J., Messika, J., Glorion, M., Sage, E., Roux, A., Brugière, O., Vallée, A., et al. (2025) · Transplant International · doi:10.3389/ti.2025.14965 · Cited by 9
“Transfusion and fl uid balance, introduced at step 9, did not enhance model performance [35, 36].”
Inhibition of DNA methylation attenuates lung ischemia–reperfusion injury after lung transplantation
Liu, M., Ju, Y., Jia, B.-W., Sun, X., Qiu, L., Liu, H.-Y., Xu, G., Tai, Q., Tan, J. H., & Gao, W. (2023) · Journal of International Medical Research · doi:10.1177/03000605231153587 · Cited by 8
“Currently, approximately 20% of patients who undergo lung transplantation experience LIRI.(3) Moreover, local inflammation and the oxidative stress response play pivotal roles in the pathology of LIRI.”
BackgroundPulmonary transplant complications: a radiologic review
Friedlander, S., Pogatchnik, B., Furuya, Y., & Allen, T. L. (2024) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-024-02731-w · Cited by 8
Ware, L. B., Koyama, T., Shaver, C. M., Swain, S., Nguyen, J., Salehi, A., Dhillon, G. S., Wickersham, N. E., Maheshwari, J. A., Singer, J. P., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.03.027 · Cited by 7
“30,31 However, in a prespecified analysis restricted to likely lung donors with less than 50 pack years of smoking, there was no difference in lung utilization between the 2 treatment arms.”
Self-citationMelnyk, V., Xu, W., Ryan, J. P., Karim, H. T., Chan, E. G., Mahajan, A., & Subramaniam, K. (2023) · Clinical Transplantation · doi:10.1111/ctr.14961 · Cited by 7
“Peak airway pressure at discharge from operating room* 30 (6) 30 (6) 30 (7) .”
BackgroundFabyan, K. D., Chandel, A., & King, C. S. (2023) · Current Pulmonology Reports · doi:10.1007/s13665-023-00311-2 · Cited by 7
Management of Pulmonary Arterial Hypertension
Weatherald, J. C., Varughese, R. A., Liu, J., & Humbert, M. J. C. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1770118 · Cited by 8
Mechanical Power Density Predicts Prolonged Ventilation Following Double Lung Transplantation
Ghiani, A., Kneidinger, N., Neurohr, C., Frank, S., Hinske, L. C., Schneider, C. P., Michel, S. G., & Irlbeck, M. (2023) · Transplant International · doi:10.3389/ti.2023.11506 · Cited by 8
“%) mechanically ventilated patients without PGD having a similar duration of mechanical ventilation, P/F ratios, MP, and power density levels.”
BackgroundInfluentialMizota, T., Miyao, M., Yamada, T., Sato, M., Aoyama, A., Chen, F., Date, H., & Fukuda, K. (2015) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivv357 · Cited by 7
Bennett, S. (2015) · World Journal of Respirology · doi:10.5320/wjr.v5.i2.78 · Cited by 8
Risks associated with lung transplantation in cystic fibrosis patients
Li, S. S., Tumin, D., Krone, K. A., Boyer, D. M., Kirkby, S. E., Mansour, H. M., & Hayes, D. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1522254 · Cited by 8
Sabashnikov, A., Mohite, P. N., Zeriouh, M., Zych, B., García‐Sáez, D., Maier, J., Weymann, A., Fatullayev, J., Mahesh, B., Popov, A., et al. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.58 · Cited by 7
“Despite utilization of ECLS in the management of iPAH, the outcomes in terms of PGD and survival remain poor. iPAH patients with end stage lung disease should be referred for LTx assessment at early stage and a higher lung allocation score should be attributed to iPAH patients on waiting lists so that they receive LTx…”
BackgroundInfluentialHanging donor lungs give good short‐, mid‐ and long‐term results in lung transplantation
Wolf, J. D., Renard, R., Lehouerou, T., Glorion, M., Pricopi, C., Bonnette, P., Parquin, F., Roux, A., Guen, M. L., Chapelier, A. R., et al. (2019) · Clinical Transplantation · doi:10.1111/ctr.13758 · Cited by 7
“In addition, no statistically significant difference was observed for the median length of ICU stay (HG 7 days [2-66] vs CG 7 days [2-91]; P = .”
BackgroundInfluentialAnaesthesia for lung transplantation
Buckwell, E., Vickery, B., & Sidebotham, D. A. (2020) · BJA Education · doi:10.1016/j.bjae.2020.07.001 · Cited by 7
“Table 2 Classification of primary graft dysfunction.(20) Note,”
BackgroundGirgis, R. E., & Hoeper, M. M. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.03.004 · Cited by 8
Schiavon, M., Madrid, A. L., Lunardi, F., Faccioli, E., Lorenzoni, G., Comacchio, G. M., Rebusso, A., Dell’Amore, A., Mammana, M., Nicotra, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112400 · Cited by 7
“the impact of donor smoking history on several early recipients’ post-operative outcomes (ICU and hospital stay), but without any impact on ventilation time and PGD rate as described by other authors [9,13,16,25].”
ResultIntraoperative Circulatory Support in Lung Transplantation: Current Trend and Its Evidence
Starke, H., von Dossow, V., & Karsten, J. (2022) · Life · doi:10.3390/life12071005 · Cited by 8
“Later data with all current therapeutic measures in both donors and recipients as well as in organ preservation suggest that an occurrence of RI in the context of PGD can be between 16% and 22%, also depending on the severity of the dysfunction [38,39].”
BackgroundNarula, T., Martin, A. K., Asif, A. A., Fritz, A. V., Li, Z. Y., Erasmus, D. B., Alvarez, F., & Thomas, M. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.01.010 · Cited by 7
Surgical Strategy for Lung Transplantation in Adults With Small Chests
Mahesh, B., Bhama, J. K., Odell, D. D., Hayanga, A. J., Bermudez, C. A., Morrell, M. R., Crespo, M. M., Pilewski, J. M., Johnson, B. A., Luketich, J. D., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001048 · Cited by 7
“Another factor thatmay contribute to the increased incidence of PGD in LLT recipients is the greater use of ECMO/CPB in the LLT group, as this is associated with a 2.2 to 3.4 greater risk of PGD.22,24 When ECMO or CPB is administered, there is a release of inflammatory mediators25-27 and a higher requirement for blood…”
BackgroundSelf-citationA global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure
Girgis, R. E., & Khaghani, A. (2016) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2016.5 · Cited by 7
What's new in pulmonary transplantation: Finding the right lung for every patient
Dark, J. H. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.024 · Cited by 7
“A key study came from Diamond and colleagues(2) of the Lung Transplant Outcomes Group in 2013.(2) In an analysis of predictors of PGD, with data collected prospectively at 10 US centers, pulmonary hypertension and recipient obesity both came out as important predictors.”
BackgroundSivakumar, S., for the PRoVENT investigators and the PROVE Network, SEMICYUC/GETGAG Working Group, TAVeM study group, POPC-CB investigators, DESIRE (DExmedetomidine for Sepsis in ICU Randomized Evaluation) Trial Investigators, GEMINI, Bioethics work group of SEMICYUC, The FINNAKI Study Group, Queen Square Neuroanaesthesia and Neurocritical Care Resreach Group, et al. (2016) · Intensive Care Medicine Experimental · doi:10.1186/s40635-016-0099-9 · Cited by 7
Primary graft dysfunction in lung transplantation: still a thorn in the side of lung transplant
Wong, K. H. M., & Hsin, K. Y. M. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1618 · Cited by 7
Michel, E., Galen Hartwig, M., & Sommer, W. (2022) · Thoracic Surgery Clinics · doi:10.1016/j.thorsurg.2021.12.001 · Cited by 6
Girgis, R. E., Manandhar-Shrestha, N., Krishnan, S., Murphy, E. T., & Loyaga‐Rendon, R. Y. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12371 · Cited by 6
“22 The basis for this observation is felt to be due, in part, to the effects of longstanding RV dysfunction with consequent underfilling, atrophy and transient dysfunction of the left ventricle (LV).”
Background
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.